Education
About Us
Working with TipRanks
Follow Us
InnovAge Holding (INNV)
NASDAQ:INNV
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.01Last Year’s EPS
-0.04Same Quarter Last Year
Moderate Sell
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 04, 2025
|% Change Since: -12.20%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive revenue and census growth, operational improvements, and strategic expansions, tempered by significant net losses, one-time financial setbacks, and challenges in enrollment processing. The company showed resilience and proactive strategies to counteract industry challenges, but financial metrics highlight ongoing difficulties.Company Guidance
During the InnovAge Fiscal Second Quarter 2025 Earnings Call, the company reaffirmed its fiscal 2025 guidance, projecting total revenue between $815 million and $865 million and adjusted EBITDA between $24 million and $31 million. The company reported a revenue increase of 10.6% year-over-year to $209 million, driven by a 10.3% growth in member months. Center level contribution margin was $37.1 million, representing a 17.7% margin. InnovAge experienced a net loss of $13.5 million, with adjusted EBITDA at $5.9 million. The census grew to 7,480 participants, and the company anticipates ending fiscal year 2025 with a census between 7,300 and 7,750. The call highlighted Medicaid rate increases in California and Pennsylvania and discussed ongoing clinical and operational initiatives aimed at margin improvement and sustainable growth.Revenue Growth
Reported revenue of $209 million for the quarter, a 10.6% increase compared to $188.9 million in the second quarter of fiscal year 2024, driven by growth in existing centers and new de novo centers.
Census Growth
Census grew to 7,480 participants, reflecting a 10.3% year-over-year increase and a 3.7% sequential increase.
Medicaid Rate Increases
Received calendar year Medicaid rate increases in California and Pennsylvania in the mid to high single digits for 2025.
Operational Improvements
Continued progress in medical cost management and operational efficiency, contributing to a 17.7% center level contribution margin, a 7% sequential improvement.
Expansion and Acquisition
Eclipsed 100 participants in the Crenshaw center, showing successful scaling of smaller PACE organizations. Acquired a pharmacy in Denver to enhance compliance and reduce costs.
---
INNV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
INNV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 04, 2025 | $3.69 | $3.36 | -8.94% |
| Nov 05, 2024 | $6.07 | $6.30 | +3.79% |
| Sep 10, 2024 | $6.18 | $5.78 | -6.47% |
| May 07, 2024 | $4.26 | $4.26 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does InnovAge Holding (INNV) report earnings?
InnovAge Holding (INNV) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is InnovAge Holding (INNV) earnings time?
InnovAge Holding (INNV) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is INNV EPS forecast?
INNV EPS forecast for the fiscal quarter 2025 (Q3) is -0.01.
---